Search Videos and More
What to Know About the Recently Approved Alzheimer’s Drug
Leqembi, Newly Approved by FDA, Shows Potential Benefit for Patients With Early-Stage Disease, But Availability Will Take Time, Says Cedars-Sinai ExpertAn AI Model of Epilepsy
Cedars-Sinai Investigators Create Computational Models of Human Epileptic Brain Circuits, Paving the Way for Deeper Understanding of the DiseaseEstrogen May Offer Protection Against Delirium
Cedars-Sinai researchers find the hormone prevents brain injury and behavioral symptoms in mice with urinary tract infections.The 14th Annual Symposium on Neurovascular Disease: Complex Neurovascular Challenges
Date & Location Saturday, January 28, 2023, 7:00 AM - 5:10 PM PST Hotel Casa Del Mar, 1910 Ocean Way, Santa Monica, CAStem Cell Study Hopes to Preserve Motor Function in ALS Patients
Stem cells have enormous potential to treat neurodegenerative disorders like amyotrophic lateral sclerosis (ALS), according to Clive Svendsen, PhD, executive director of the Board of Governors Regenerative Medicine Institute and the Kerry and Simone Vickar Family Foundation Distinguished Chair in Regenerative Medicine at Cedars-Sinai.The Impact of Immunotherapy on the Brain
Chemotherapy is a blunt instrument: It kills cancer, along with everything else in its wake. Immunotherapy, conversely, has a laserlike focus and can specifically target diseased cells.New Data Provide Novel Insight Into Error Monitoring and the Formation of Memories
Cedars-Sinai is home to a level 4 epilepsy center and one of the few epilepsy monitoring units in the Los Angeles area. Here, experts can observe patients and their seizure activity in real time with the goal of reducing the frequency and burden of seizures in the future.Telestroke Program and Clinical Trials Expand the Reach of Lifesaving Stroke Care
When someone suffers a stroke, the medical intervention response time can mean life or death.That is why Cedars-Sinai physicians Shlee Song, MD, director of the Comprehensive Stroke Center and Telestroke Program, and Michael Alexander, MD, director of the Neurovascular Center and Endovascular Neurosurgery, are so passionate about stroke care expansion and advancement.AI: Cedars-Sinai Awarded $8M to Study Alzheimer’s Disease
Investigators to Use Artificial Intelligence and Machine Learning Methods to Crunch Data and Identify Genetic PredictorsCedars-Sinai Parkinson's Disease Annual Symposium: A Holistic Approach
Saturday, October 15, 2022, 7:30 AM - 3:45 PM PST JW Marriott Santa Monica Le Merigot Santa Monica, CALatest Updates on Neuroimmunology: 7th Annual Conference for Healthcare Professionals and Patients
Date & Location Saturday, December 3, 2022, 8:00 AM - 1:00 PM PST Virtual, Los Angeles, CAAbout the Neurocritical Care Fellowship | Cedars-Sinai Academic Medicine
The Cedars-Sinai Neurocritical Care Fellowship program is accredited by the United Council for Neurologic Subspecialties (UCNS) and geared toward highly motivated individuals who are interested in pursuing academic or clinical careers.